Lineage Cell Therapeutics Inc.
LCTX | TA
Overview
Corporate Details
- ISIN(s):
- US53566P1093
- LEI:
- Country:
- Israel
- Address:
- Derech Menachem Begin 121, 6701203 Tel Aviv
- Website:
- https://lineagecell.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Lineage Cell Therapeutics develops cell-based therapies for age-related diseases and degenerative conditions.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-23 20:53 |
Proxy Solicitation & Information Statements
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held June 26, 2025
|
English | 2.8 MB | |
| 2025-06-23 20:53 |
Proxy Solicitation & Information Statements
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held June 26, 2025
|
English | 36.5 KB | |
| 2025-05-14 12:01 |
Earnings Release
First Quarter 2025 Financial Results and Provides Business Update
|
English | 64.9 KB | |
| 2025-05-14 12:01 |
Earnings Release
First Quarter 2025 Financial Results and Provides Business Update
|
English | 36.5 KB | |
| 2025-05-14 11:23 |
Regulatory News Service
The company's financial results for the First quarter of 2025 were reported abr…
|
Hebrew (modern) | 82.6 KB | |
| 2025-03-11 11:29 |
Earnings Release
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial R…
|
English | 71.6 KB | |
| 2025-03-11 11:29 |
Foreign Filer Report
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial R…
|
English | 36.7 KB | |
| 2025-03-11 10:26 |
Regulatory News Service
The company's financial results for the Fourth quarter and full year 2024 were …
|
Hebrew (modern) | 83.1 KB | |
| 2025-01-28 12:24 |
Regulatory News Service
Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Ann…
|
English | 30.5 KB | |
| 2025-01-28 12:24 |
Regulatory News Service
Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Ann…
|
English | 36.5 KB | |
| 2024-11-26 11:05 |
Directors' Dealings
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP- Mulroy Michael H
|
English | 110.2 KB | |
| 2024-11-26 11:05 |
Directors' Dealings
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP- Mulroy Michael H
|
English | 36.4 KB | |
| 2024-11-25 11:20 |
Directors' Dealings
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP - Culley Brian M
|
English | 115.3 KB | |
| 2024-11-25 11:20 |
Directors' Dealings
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP - Culley Brian M
|
English | 36.4 KB | |
| 2024-11-24 16:33 |
Major Shareholding Notification
SCHEDULE 13D/A -Broadwood, Neal C. Bradsher
|
English | 167.2 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |